E. Grossman et al., HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF FISH-OIL IN HYPERTENSIVE PATIENTS, American journal of hypertension, 6(12), 1993, pp. 1040-1045
Recent studies showed that supplementation of a large dose of fish oil
is effective in lowering blood pressure. Whether supplementation of a
low dose of fish oil is also effective in lowering blood pressure is
controversial. The present study evaluates the hemodynamic and humoral
effects of low-dose dietary fish oil supplementation in patients with
mild hypertension. Eleven patients with mild hypertension were given
3 g/day of n-3 polyunsaturated fatty acids for 6 week. Twenty-four hou
r blood pressure monitoring and humoral parameters were recorded befor
e and during fish oil treatment. In five patients, blood pressure resp
onse to angiotensin II (AII) infusion (1, 2, 3, 6, 9 ng/kg/min) was al
so recorded before and during treatment. Casual mean arterial pressure
was unchanged (111+/-1 mm Hg v 109+/-3 mm Hg; P=NS). Average 24-h mea
n arterial pressure (MAP) also did not change during fish oil treatmen
t (98+/-2 mm Hg v 99+/-3 mm Hg; P=NS). Fish oil supplementation did no
t attenuate the vascular reactivity to AII infusion. Maximal MAP follo
wing All infusion (9 ng/kg/min) was 128+/-5 mm Hg before and 129+/-7 m
m Hg during fish oil treatment (P=NS). Plasma levels of norepinephrine
, renin activity, aldosterone, and atrial natriuretic peptide remained
unchanged during treatment. Plasma levels of total cholesterol slight
ly increased from 200+/-10 mg/dL to 211+/-9 mg/dL (P<.05), but plasma
levels of high-density lipoprotein (HDL) cholesterol, low-density lipo
protein (LDL) cholesterol, and triglycerides were unaffected. A low do
se of fish oil supplementation failed to lower MAP and did not attenua
te the pressure increase following AII infusion. Thus, the use of low-
dose fish oil as an antihypertensive agent should be reconsidered.